Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Myositis”

83 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 83 results

Early research (Phase 1)Looking for participantsNCT06980597
What this trial is testing

OL-108 in Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Idiopathic Inflammatory Myopathy (IIM)Systemic Sclerosis (SSc)+1 more
Beijing GoBroad Hospital 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07778446
What this trial is testing

Test CRT-402 in Refractory Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus ErythematosusSystemic Scleroderma+1 more
Myeloid Therapeutics 34
Early research (Phase 1)Looking for participantsNCT07715136
What this trial is testing

BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy

Who this might be right for
Inflammatory Myopathy
iCell Gene Therapeutics 10
Early research (Phase 1)Enrolling By InvitationNCT07038447
What this trial is testing

KITE-363 in Participants With Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisSystemic Sclerosis+1 more
Kite, A Gilead Company 52
Testing effectiveness (Phase 2)Looking for participantsNCT06857240
What this trial is testing

Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis

Who this might be right for
Dermatomyositis
The Cleveland Clinic 15
Early research (Phase 1)Not Yet RecruitingNCT07490275
What this trial is testing

Allogeneic CD19/BCMA-Targeted CAR-γδT Cell Therapy: Safety and Preliminary Pharmacodynamics in Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Refractory/Relapsed Systemic Lupus ErythematosusRefractory / Relapsed / Progressive Systemic SclerosisRefractory / Relapsing / Progressive Inflammatory Myopathy+2 more
Institute of Hematology & Blood Diseases Hospital, China
Early research (Phase 1)Study completedNCT00010335
What this trial is testing

Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders

Who this might be right for
Systemic SclerosisSystemic Lupus ErythematosusDermatomyositis+2 more
Fred Hutchinson Cancer Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT06828042
What this trial is testing

Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErthematosusSystemic Sclerosis (SSc)Sjogren Syndrome+3 more
Peking University Third Hospital 9
Early research (Phase 1)Looking for participantsNCT07236762
What this trial is testing

An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis (LN)Sjogren's Syndrome+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Not applicableLooking for participantsNCT07558850
What this trial is testing

Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases

Who this might be right for
Rheumatoid ArthritisDermatomyositisSystemic Lupus Erythematosus+1 more
The First Affiliated Hospital with Nanjing Medical University 72
Testing effectiveness (Phase 2)Looking for participantsNCT06794008
What this trial is testing

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusInflammatory MyopathySystemic Sclerosis (SSc)+6 more
Peking University People's Hospital 50
Very early researchUnknownNCT04946669
What this trial is testing

An Exploratory Study on the Efficacy and Safety of Abatacept in the Treatment of Refractory Dermatomyositis

Who this might be right for
DermatomyositisAbatacept
The First Affiliated Hospital with Nanjing Medical University 20
Large-scale testing (Phase 3)Study completedNCT02347891
What this trial is testing

Belimumab in Idiopathic Inflammatory Myositis

Who this might be right for
Myositis
Northwell Health 17
Large-scale testing (Phase 3)Study completedNCT01165008
What this trial is testing

Anakinra in Myositis

Who this might be right for
PolymyositisDermatomyositisInclusion Body Myositis
Karolinska Institutet
Very early researchNot Yet RecruitingNCT07674147
What this trial is testing

RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases

Who this might be right for
Autoimmune DiseasesSLE - Systemic Lupus ErythematosusSSc-Systemic Sclerosis+3 more
The Children's Hospital of Zhejiang University School of Medicine 30
Testing effectiveness (Phase 2)Study completedNCT01906372
What this trial is testing

Acthar in Treatment of Refractory Dermatomyositis and Polymyositis

Who this might be right for
DermatomyositisPolymyositis
Rohit Aggarwal, MD 12
Early research (Phase 1)Looking for participantsNCT06686524
What this trial is testing

Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM)

Who this might be right for
Dermatomyositis, JuvenileDermatomyositis
Chongqing Precision Biotech Co., Ltd 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06821659
What this trial is testing

Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined With Immunosuppressants in the Treatment of Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErthematosusSystemic Sclerosis (SSc)Inflammatory Myopathies+2 more
Peking University Third Hospital 9
Early research (Phase 1)Looking for participantsNCT07115745
What this trial is testing

Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

Who this might be right for
Refractory Autoimmune Diseases
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 125
Very early researchUnknownNCT06417398
What this trial is testing

Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusIdiopathic Inflammatory MyopathiesSystemic Sclerosis+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Next Page
9